<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">ppharm-1122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>В ПРАКТИКУ ПЕДИАТРА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>For Pediatricians' Practice</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТИВНОСТЬ ДИФФЕРЕНЦИРОВАННЫХ СХЕМ ЛЕЧЕНИЯ ЦЕФАЛГИЙ У ДЕТЕЙ И ПОДРОСТКОВ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>EFFICACY OF DIFFERENT TYPES OF TREATMENT OF CEPHALGIA IN CHILDREN AND ADOLESCENTS WITH ARTERIAL HYPERTENSION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рахимова</surname><given-names>А.Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rakhimova</surname><given-names>A.N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тамбовцева</surname><given-names>В.И.</given-names></name><name name-style="western" xml:lang="en"><surname>Tambovtseva</surname><given-names>V.I.</given-names></name></name-alternatives><bio xml:lang="en"/><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пальцева</surname><given-names>А.Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Pal'zeva</surname><given-names>A.E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васильченко</surname><given-names>В.В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasil'chenko</surname><given-names>V.V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кожевникова</surname><given-names>О.В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozhevnikova</surname><given-names>O.V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Научный центр здоровья детей РАМН, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Center of Children’s Health, Russian Academy of Medical Sciences, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>07</day><month>12</month><year>2015</year></pub-date><volume>7</volume><issue>4</issue><issue-title>Педиатрическая фармакология</issue-title><fpage>72</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Рахимова А., Тамбовцева В., Пальцева А., Васильченко В., Кожевникова О., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Рахимова А., Тамбовцева В., Пальцева А., Васильченко В., Кожевникова О.</copyright-holder><copyright-holder xml:lang="en">Rakhimova A., Tambovtseva V., Pal'zeva A., Vasil'chenko V., Kozhevnikova O.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/1122">https://www.pedpharma.ru/jour/article/view/1122</self-uri><abstract><p>Изучена эффективность комплексной терапии цефалгий у 201 ребёнка в возрасте от 7 до 17 лет с различными формами артериальной гипертензии с помощью суточного мониторирования артериального давления и транскраниальной допплерографии сосудов головного мозга. Лечение проводилось курсами в течение 36 месяцев. Результаты оценивались через 18 и 36 месяцев от начала лечения. Определена тактика лечения цефалгий у детей и подростков в зависимости от формы артериальной гипертензии и особенностей церебральной гемодинамики. Ключевые слова: цефалгии, артериальная гипертензия, суточное мониторирование артериального давления, транскраниальная допплерография, дисфункции вегетативной нервной системы, дети. </p><p>(Педиатрическая фармакология. – 2010; 7(4):72-80)</p></abstract><trans-abstract xml:lang="en"><p>Examined was the efficacy of integrated therapy for cephalgia syndrome in 201 children aged 7 to 17 years with various forms of arterial hypertension through daily monitoring of arterial pressure and transcranial dopplerography of brain vessels. Treatment was performed in courses over 3 years. Results were assessed at 1,5 and 3 years from the launch of treatment. Tactics were determined for treating cephalgia syndrome in children and adolescents depending of the form of arterial hypertension and specifics and cerebral hemodynamics. Key words: cephalgia, arterial hypertension, daily monitoring of arterial pressure, transcranial dopplegraphy, disorders of the vegetative nervous system, children. </p><p>(Pediatric Pharmacology. – 2010; 7(4):72-80)</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
